Patents Assigned to Stevia Limited
  • Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
    Patent number: 9636314
    Abstract: A dietary supplement or medicament comprising a substance including the chemical structure of bicyclo [3.2.1]octan or the chemical structure of kaurene. The medicament is useful for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The possible substances include steviol, isosteviol or stevioside.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: May 2, 2017
    Assignee: Stevia Limited
    Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix Jeppesen